India Makes Global Medical Mark: AIIMS Delhi Ranked 6th, Tata Memorial 13th Among World’s Top Hospitals 2026

New Delhi: India's premier medical institutions, All India Institute of Medical Sciences (AIIMS), New Delhi, and the Tata Memorial Centre (TMC), Mumbai, have both secured 6th and 13th rank, respectively, on the 2026 Brand Finance Global Top 250 Hospitals report.

Both secured prestigious spots, signalling the country’s rising influence in the global healthcare economy.

The report, released on February 5, 2026, at the London Stock Exchange, ranks AIIMS Delhi 6th globally in terms of brand strength. 

This ranking makes it the leader in South Asia, surpassing several long-standing Academic Medical Centres (AMCs) from Europe and North America.

India’s Leading Brands

The recognition of these institutions highlights a dual victory for India’s public healthcare sector, showcasing excellence in both general multispecialty care and highly specialised oncology.

1. AIIMS, New Delhi (Rank 6)

With a Brand Strength Index (BSI) score of 79.9/100, AIIMS was lauded for its massive research output and its role as a primary training ground for world-class clinicians. 

The report noted that AIIMS enjoys near-universal awareness among healthcare professionals globally, particularly for its ability to manage high patient volumes with clinical precision.

2. Tata Memorial Centre, Mumbai (Rank 13)

Featured prominently in the specialised rankings, TMC Mumbai was recognised as a global powerhouse in oncology. 

As the "Harvard of Indian Oncology", TMC’s inclusion in the top 100 reflects its pioneering work in cancer research, affordable treatment protocols, and its leadership in the Department of Atomic Energy-backed medical initiatives.

Global Context

Globally, Johns Hopkins Medicine and Oxford University Hospitals retained the top two spots. However, the 2026 report emphasises that the gap between Western and Asian brands is closing.

The report also highlighted that Indian hospitals are increasingly viewed as leaders in "value-based care", successfully integrating advanced technologies like generative AI and robotic-assisted surgery at a fraction of the cost seen in Western markets. (The data for this visualisation was sourced from the Global Top 250 Hospitals 2025 Report.)

Also Read: Bat Virus PRV Emerges In Bangladesh, Should India Be Worried About Its Spread?